Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
67.40
-1.03 (-1.51%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
45
46
Next >
Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today
↗
January 10, 2024
Via
Benzinga
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
↗
January 09, 2024
Last year wasn't great for either stock, but that's no reason to ignore them.
Via
The Motley Fool
History Says the Nasdaq Will Soar in 2024: 1 Stock-Split AI Growth Stock to Buy Now and Hold Forever
↗
January 09, 2024
Nvidia is well positioned to create value for patient shareholders, given its leadership in artificial intelligence chips.
Via
The Motley Fool
Topics
Artificial Intelligence
3 Stocks to Capitalize on the Telehealth Explosion
↗
January 08, 2024
These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.
Via
InvestorPlace
Dexcom's Recent 66% Run Continues With A Breakout On Bullish Fourth-Quarter Sales
↗
January 08, 2024
Dexcom beat fourth-quarter sales expectations and issued stronger-than-usual annual guidance.
Via
Investor's Business Daily
A Closer Look at DexCom's Options Market Dynamics
↗
January 08, 2024
Via
Benzinga
Is NASDAQ:DXCM a Fit for Growth Investing Strategies?
↗
January 04, 2024
Should you consider DEXCOM INC (NASDAQ:DXCM) for growth investing?
Via
Chartmill
The Latest Analyst Ratings For DexCom
↗
January 03, 2024
Via
Benzinga
DexCom Unusual Options Activity
↗
January 02, 2024
Via
Benzinga
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook
January 08, 2024
From
DexCom, Inc.
Via
Business Wire
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
January 08, 2024
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.
Via
MarketBeat
Topics
ETFs
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
↗
January 03, 2024
Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase.
Via
Chartmill
1 Stock-Split Stock to Buy Hand Over Fist in 2024 and 1 to Avoid
↗
January 03, 2024
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer that's ripe for the picking, as well as an...
Via
The Motley Fool
Looking Into DexCom's Recent Short Interest
↗
December 22, 2023
Via
Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $21,000 Today
↗
December 21, 2023
Via
Benzinga
For those who appreciate growth without the sticker shock, NASDAQ:DXCM is worth considering.
↗
January 02, 2024
NASDAQ:DXCM stands out as a growth opportunity that won't break the bank.
Via
Chartmill
These 3 Companies Can Be the Next Stock-Split Stocks in 2024
↗
December 29, 2023
Since mid-2021, Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk have conducted stock splits. Three well-known companies look set to follow in...
Via
The Motley Fool
Meet the Stock-Split Stock Warren Buffett Is Likeliest to Buy in 2024
↗
December 27, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a stock-split stock that checks all the right boxes for the Oracle of Omaha.
Via
The Motley Fool
3 Stock-Split Stocks Billionaires Are Piling Into Ahead of 2024
↗
December 25, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry leaders Wall Street's brightest money managers want to own for...
Via
The Motley Fool
DexCom's Options Frenzy: What You Need to Know
↗
December 20, 2023
Via
Benzinga
DEXCOM INC (NASDAQ:DXCM) showing high EPS and FCF growth while beating expectations
↗
December 13, 2023
DEXCOM INC (NASDAQ:DXCM) may be suited for growth investing, we'll explore why in this article.
Via
Chartmill
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
↗
December 12, 2023
DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.
Via
Chartmill
Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
DexCom, Inc.
Via
Business Wire
3 Stock-Split Stocks With 51% to 128% Upside in 2024, According to Select Wall Street Analysts
↗
December 18, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three high-flying stocks a trio of Wall Street analysts believe can soar in the...
Via
The Motley Fool
Pet Parents Keep Spending
↗
December 13, 2023
We also talk with Dexcom CEO Kevin Sayer about the impact of weight loss drugs on diabetes care.
Via
The Motley Fool
NASDAQ:DXCM is showing decent growth, but is still valued reasonably.
↗
December 11, 2023
NASDAQ:DXCM is not too expensive for the growth it is showing.
Via
Chartmill
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,800 Today
↗
December 07, 2023
Via
Benzinga
(DXCM) - Analyzing DexCom's Short Interest
↗
December 06, 2023
Via
Benzinga
Market Whales and Their Recent Bets on DXCM Options
↗
December 05, 2023
Via
Benzinga
Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump
December 06, 2023
From
DexCom, Inc.
Via
Business Wire
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
45
46
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today